Frankfurt - Delayed Quote EUR

IRADIMED CORPORATION (46K.F)

51.00
+5.60
+(12.33%)
At close: May 30 at 8:01:50 AM GMT+2
Loading Chart for 46K.F
  • Previous Close 45.40
  • Open 51.00
  • Bid 50.50 x --
  • Ask 51.50 x --
  • Day's Range 51.00 - 51.00
  • 52 Week Range 38.80 - 61.00
  • Volume 53
  • Avg. Volume 7
  • Market Cap (intraday) 739.316M
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) 36.96
  • EPS (TTM) 1.38
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield 0.60 (1.33%)
  • Ex-Dividend Date May 20, 2025
  • 1y Target Est --

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

www.iradimed.com

160

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 46K.F

View More

Performance Overview: 46K.F

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

46K.F
0.68%
S&P 500 (^GSPC)
0.51%

1-Year Return

46K.F
32.52%
S&P 500 (^GSPC)
12.92%

3-Year Return

46K.F
77.19%
S&P 500 (^GSPC)
42.17%

5-Year Return

46K.F
177.46%
S&P 500 (^GSPC)
94.19%

Compare To: 46K.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 46K.F

View More

Valuation Measures

Annual
As of 5/29/2025
  • Market Cap

    658.13M

  • Enterprise Value

    613.38M

  • Trailing P/E

    32.90

  • Forward P/E

    28.99

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.69

  • Price/Book (mrq)

    7.20

  • Enterprise Value/Revenue

    9.17

  • Enterprise Value/EBITDA

    29.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.33%

  • Return on Assets (ttm)

    14.92%

  • Return on Equity (ttm)

    23.81%

  • Revenue (ttm)

    75.15M

  • Net Income Avi to Common (ttm)

    19.78M

  • Diluted EPS (ttm)

    1.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    50.33M

  • Total Debt/Equity (mrq)

    0.07%

  • Levered Free Cash Flow (ttm)

    8.58M

Research Analysis: 46K.F

View More

Company Insights: 46K.F

Research Reports: 46K.F

View More

People Also Watch